About Civilization Ventures
Civilization Ventures is a venture capital firm founded in 2017. It is primarily based out of San Francisco, United States. As of Jun 2026, Civilization Ventures is an active investor, having invested in 77 companies, with 8 new investments in the last 12 months. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series A round of Syntax Bio Overall, Civilization Ventures portfolio has seen 1 unicorn, 3 IPOs and 12 acquisitions including key companies like Omada, BillionToOne and Icebreaker Health. A lot of funds co-invest with Civilization Ventures, with names like Artis Ventures sharing a substantial percentage of its portfolio. Civilization Ventures has team of 23 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Deals in last 12 months
Civilization Ventures' List of Top Investments
Civilization Ventures has a portfolio of 77 companies, one of which is a Unicorn. Their most notable investments are in Foresight Diagnostics and Foresight Diagnostics.Their portfolio spans across United States, United Kingdom, Australia and 3 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 14 other sectors, across stages such as Series A, Seed and 3 more. Here is the list of top investments by Civilization Ventures:
1. Omada
Provider of virtual care programs to manage chronic diseases. The company provides access to personal health coaches and specialists for virtual programs to deliver personalized interventions for prediabetes, diabetes, hypertension, and musculoskeletal issues.
Key facts about Omada
- Founded Year: 2011
- Location: San Francisco (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $450M
- Employee Count: 987 as on May 31, 2026
- Investors: Fidelity Investments, Carriage House Rock and 44 Others
- Latest Funding Round: Series E, Feb 23, 2022, $*****
- Highlight: Public
2. BillionToOne
Provider of cell-free cancer liquid biopsy test. The company provides a molecular counter platform to count the DNA molecules from blood samples. It provides genetic tests for cystic fibrosis, spinal muscular atrophy, sickle cell disease, etc.
Key facts about BillionToOne
- Founded Year: 2015
- Location: San Francisco (United States)
- Stage: Public
- Total Funding till date: $389M
- Employee Count: 787 as on May 31, 2026
- Investors: Adams Street Partners, Oberland Capital and 31 Others
- Latest Funding Round: Series D, Jun 21, 2024, $*****
- Highlight: Public
Developer of bioprinting technology and tissue therapeutics for regenerative medicine. The company’s platform integrates bioprinting, computational design, therapeutic cells, and biomaterials. It develops implantable tissues to replace, repair, or supplement biological functions. The focus is on creating solutions for metabolic and endocrine diseases. The company also collaborates with other organizations.
Key facts about Aspect Biosystems
- Founded Year: 2013
- Location: Vancouver (Canada)
- Stage: Series B
- Total Funding till date: $139M
- Employee Count: 145 as on May 31, 2026
- Investors: Rising Tide Fund, Canadian Space Agency and 21 Others
- Latest Funding Round: Series B, Jan 08, 2025, $*****
- Highlight: Editors' Pick
4. Antheia
Antheia is focused on developing medicines using its technology. Its technology combines synthetic biology, informatics, and fermentation technology to provide plant-based medicines. It is currently working on engineering the yeast cells genetically to produce natural medicinal products.
Key facts about Antheia
- Founded Year: 2013
- Location: Palo Alto (United States)
- Stage: Series C
- Total Funding till date: $176M
- Employee Count: 66 as on May 31, 2026
- Investors: EDBI, In-Q-Tel and 15 Others
- Latest Funding Round: Series C, Jan 27, 2026, $*****
- Highlight: Editors' Pick
Lemonaid is an app, a part of Icebreaker Health, that offers patient counselling for conditions like acid reflux, erectile dysfunction, flu, hair loss, urinary tract infections and prescription of birth control pills. The visits cost $15 a piece and the company promises a two-hour turnaround time. After the patient fills out a questionnaire, the doctor can write them a prescription and send it to a local pharmacy. User can pick up their prescription and pay at the pharmacy.
Key facts about Icebreaker Health
- Founded Year: 2014
- Location: San Francisco (United States)
- Stage: Acquired
- Total Funding till date: $64.7M
- Employee Count: 182 as on Dec 31, 2022
- Investors: Sierra Ventures, Firebolt Ventures and 14 Others
- Latest Funding Round: Series B, Jul 31, 2020, $*****
- Highlight: Acquired
Civilization Ventures' Year-on-Year Investment Trends
Civilization Ventures has invested in 77 companies over the last 9 years, with an average of 5 new investments annually in the last 5 years. In 2025, it made 6 investments, while as of Jun 2026, it has made 4 investments in this year. Its most recent first time investment was in Syntax Bio and most recent follow-on round was in Oxford Cancer Analytics.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 4 | 0 | 4 |
2025 | 5 | 1 | 6 |
2024 | 3 | 3 | 6 |
2023 | 5 | 3 | 8 |
2022 | 2 | 2 | 4 |
2021 | 8 | 1 | 9 |
2020 | 2 | 1 | 3 |
2019 | 3 | 1 | 4 |
2018 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
Civilization Ventures' Investments by Stage
Civilization Ventures has made 16 investments in Series A stage with an average round size of $16.9M, 15 investments in Seed stage with an average round size of $6.71M, 2 investments in Series C stage with an average round size of $49M, 1 investment in Series B stage with an average round size of $30M and 1 investment in Series D stage with an average round size of $50M.Stage of entry | No. of Investments |
|---|---|
Series A | 16 |
Seed | 15 |
Series C | 2 |
Series B | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
Civilization Ventures' Investments by Sector
Civilization Ventures has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, High Tech, Enterprise Applications and Healthcare. Notably, it has invested in 68 Tech companies, 61 Enterprise (B2B) companies, 29 Software companies and at least 12 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 23 |
HealthTech | 10 |
High Tech | 10 |
Enterprise Applications | 6 |
Healthcare | 6 |
Others | 5 |
Note: We have considered here, only first round of investments
Civilization Ventures' Investments by Geography
Civilization Ventures has made most investments in United States (31), followed by Australia where it has made 2 investments.Country | No. of Investments |
|---|---|
United States | 31 |
Australia | 2 |
United Kingdom | 2 |
Brazil | 1 |
Note: We have considered here, only first round of investments
Civilization Ventures' recent investments
Civilization Ventures has made 4 investments in 2026 so far. Syntax Bio and Syntaxbio.com are the latest among them.Here are the most recent investments by Civilization Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 22, 2026 | United States | Series A | 7693 | ||
Jun 21, 2026 | Australia | Series A | 9386 | ||
Apr 22, 2026 | United States | Seed | 9609 | [+1] | |
Mar 09, 2026 | United States | Series A | 1829 | [+1] | |
Dec 02, 2025 | United States | Series A | 5287 | [+5] |
Unicorns in Civilization Ventures' Portfolio
Civilization Ventures has 1 unicorn in its portfolio - Ample. The most recent unicorn in their portfolio is Ample which became a unicorn in 2021, 4 years before Civilization Ventures first invested in it.Here is a list of unicorns in Civilization Ventures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
64 | Provider of modular battery swapping for electric vehicles | 2014 | San Francisco | Series D | fokyvtg |
IPOs and Publicly Listed companies in Civilization Ventures' Portfolio
3 of Civilization Ventures' portfolio companies have become public. BillionToOne got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Nov 2025 at marketcap of $2.41B and Omada got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $1.06B.Here are Civilization Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 06, 2025 | Mar 28, 2019 | Series A | 5465 | |
Jun 06, 2025 | Jun 14, 2017 | Series D | 1876 | |
Apr 30, 2015 | - | - | 3503 |
Acquired companies in Civilization Ventures' Portfolio
12 companies from Civilization Ventures' portfolio have been acquired. The most recent acquisition was Foresight Diagnostics in Dec 2025 by Natera for $*****.Here are Civilization Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 11, 2025 | Jun 02, 2021 | Series A | 4571 | |
Apr 07, 2025 | - | - | 9599 | |
Oct 22, 2024 | - | - | 9835 | |
Sep 04, 2024 | - | - | 2416 | |
Jul 09, 2024 | 2020 | Series A | 5003 |
Team profile of Civilization Ventures
Civilization Ventures has a team of 23 members including 2 Partners and 1 Principal located in United States. Civilization Ventures' team does not sit on the board of any company as of now.Here is a list of top team members in Civilization Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Francisco | - | ||
Partner | Mountain View | - | ||
Principal | San Francisco | - | - |
Co-investors of Civilization Ventures
Over the past 9 years, 264 investors have co-invested in Civilization Ventures's portfolio companies. This includes funds and angels.
- Invested before Civilization Ventures: Y Combinator, HHS and 42 others have invested in rounds before Civilization Ventures. There are 5 companies where Y Combinator has invested before Civilization Ventures and 4 companies where HHS has invested before Civilization Ventures.
- Top Co-investors of Civilization Ventures: 149 investors entered a company along with Civilization Ventures. These include investors like Artis Ventures (4 companies).
- Invested after Civilization Ventures: A total of 71 investors have invested in Civilization Ventures's portfolio after their investments. Top Investors include HHS (3 companies), Perceptive Advisors (2 companies) and Foresite Capital (2 companies).
Recent News related to Civilization Ventures
•
Trial Library Secures $10M Series A to Expand Clinical Trial Matching to InsurersEndpoints•Dec 02, 2025•Trial Library, Overwater Ventures, How Women Invest, SemperVirens and 6 others
•
Curve Biosciences Raises $40M for Blood-Based Chronic Disease MonitoringInside Precision Medicine•Oct 30, 2025•Curve Biosciences, Luma, Life Extension Ventures, Civilization Ventures and 1 other
•
AP Iantrek Secures $42M Series C for AlloFlo™ Uveo Launch and Pipeline ExpansionBakersfield•Aug 20, 2025•Iantrek, Sectoral, Visionary Ventures, Civilization Ventures and 3 others
•
Oxford Cancer Analytics brings in US$11m in Series A fundingThe Business Magazine•Aug 14, 2025•OKG Capital, We Venture Capital, Oxford Cancer Analytics, Impact Ventures and 5 others
•
Tahoe Therapeutics secures $30M to advance AI models for medical researchSiliconAngle•Aug 12, 2025•Tahoe Bio, Amplify, Databricks, Amplify Partners and 8 others
•
Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategyintelligence360•Jun 16, 2025•SG Growth Capital, Global Health Investment, Singapore Economic Development Board, S-Cubed Capital and 6 others
•
Antheia Scores $56 Million Series Csvdaily.com•Jun 06, 2025•Antheia, Global Health Investment, EDBI, Athos Capital and 5 others
•
Oxford Cancer Analytics Raises USD$11M in Series A FundingFinSMEs•Jan 09, 2025•Oxford Cancer Analytics, We Venture Capital, Cross Border Impact Ventures, Eka Ventures and 6 others
•
Integrated Biosciences Raises $17 Million to Accelerate Development of Drugs Targeting Age-Related DiseasesBusiness Wire•Oct 03, 2024•Integrated Biosciences, Sutter Hill Ventures, Root Ventures, Civilization Ventures and 9 others
•
Halda Therapeutics Raises $126M in Series B Extension FinancingFinSMEs•Aug 12, 2024•Halda Therapeutics, Deep Track Capital, Frazier Life Sciences, RA Capital Management and 22 others
